Skip to main content
Caplight Logo









Convergent Bio

Convergent Bio

Private
Dover, DelawareHealthcare & Life Scienceshttps://convergent-bio.com/

Last Round

Accelerator

Aug 22, 2024

Company Overview

Convergent Bio is an agtech company that develops sustainable agriculture technologies using a multidisciplinary approach of bioconvergence, biodelivery, and biosystems.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Medical AI, ML Platforms, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Revenue Share, Usage-Based SaaS

AI Layer

Foundation

Keywords

AI drug discoverygenerative biologybio foundation modelAI biotechLLMsin silico drug discoverylarge language modelstarget discoveryantibody optimizationbioinformatics platformbiomarker discoveryfoundation modelsfrontier AI labcomputational biologygene expression optimizationprotein manufacturingprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Convergent Bio Comparables

Compare Convergent Bio with similar companies based on industry and business-model similarity.

Convergent Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EvolutionaryScale
84%
Chai Discovery
79%
Cradle
78%

Convergent Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorAug 22, 2024

Convergent Bio Investors

Notable investors and investment history

Convergent Bio investors
InvestorRounds
Plug and Play TopekaAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2024

    Received funding from Plug and Play Topeka.

Convergent Bio Filings

Explore SEC and related filing metadata, where available.

Convergent Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Convergent Bio's valuation, stock price, and market status.

Is Convergent Bio a public or private company?

Convergent Bio is a private company.

What is the current stock price of Convergent Bio?

Convergent Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Convergent Bio worth (valuation)?

Valuation information for Convergent Bio is not publicly available.

Can I buy Convergent Bio stock?

Convergent Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Convergent Bio's last funding round?

Funding round information for Convergent Bio is not publicly available.

Who are the main investors in Convergent Bio?

Investor information for Convergent Bio is not publicly disclosed.

Will Convergent Bio IPO soon?

No public IPO plans have been announced for Convergent Bio.

How can I track Convergent Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Convergent Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDover, Delaware
Employee Range4
Year Founded2023
Last FundingAug 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?